» Articles » PMID: 38793012

Healing of Periodontal Suprabony Defects Following Treatment with Open Flap Debridement with or Without Hyaluronic Acid (HA) Application

Overview
Publisher MDPI
Specialty General Medicine
Date 2024 May 25
PMID 38793012
Authors
Affiliations
Soon will be listed here.
Abstract

This randomized, double-arm, multicentric clinical trial aims to compare the clinical outcomes following the treatment of suprabony periodontal defects using open flap debridement (OFD) with or without the application of hyaluronic acid (HA). Sixty systemically healthy patients with at least two teeth presenting suprabony periodontal defects were randomly assigned with a 1:1 allocation ratio using computer-generated tables into a test (OFD + HA) or control group (OFD). The main outcome variable was clinical attachment level (CAL). The secondary outcome variables were changes in mean probing pocket depth (PPD), gingival recession (GR), full-mouth plaque score (FMPS), and full-mouth bleeding score (FMBS). All clinical measurements were carried out at baseline and 12 months. Sixty patients, thirty in each group, were available for statistical analysis. The mean CAL gain was statistically significantly different ( < 0.001) in the test group compared with the control group (3.06 ± 1.13 mm vs. 1.44 ± 1.07 mm). PPD reduction of test group measurements (3.28 ± 1.14 mm) versus the control group measurements (2.61 ± 1.22 mm) were statistically significant ( = 0.032). GR changes were statistically significant only in the test group 0.74 ± 1.03 mm ( < 0.001). FMBS and FMPS revealed a statistically significant improvement mostly in the test group. Suprabony periodontal defects could benefit from the additional application of HA in conjunction with OFD in terms of improvement of the clinical parameters compared with OFD alone.

References
1.
Jentsch H, Purschwitz R . A clinical study evaluating the treatment of supra-alveolar-type defects with access flap surgery with and without an enamel matrix protein derivative: a pilot study. J Clin Periodontol. 2008; 35(8):713-8. DOI: 10.1111/j.1600-051X.2008.01253.x. View

2.
Choi S, Yoo M, Lee S, Lee H, Son D, Jung J . Modulation of biomechanical properties of hyaluronic acid hydrogels by crosslinking agents. J Biomed Mater Res A. 2015; 103(9):3072-80. DOI: 10.1002/jbm.a.35437. View

3.
Chen W, Abatangelo G . Functions of hyaluronan in wound repair. Wound Repair Regen. 1999; 7(2):79-89. DOI: 10.1046/j.1524-475x.1999.00079.x. View

4.
Ijuin C, Ohno S, Tanimoto K, Honda K, Tanne K . Regulation of hyaluronan synthase gene expression in human periodontal ligament cells by tumour necrosis factor-alpha, interleukin-1beta and interferon-gamma. Arch Oral Biol. 2001; 46(8):767-72. DOI: 10.1016/s0003-9969(01)00032-2. View

5.
Eliezer M, Imber J, Sculean A, Pandis N, Teich S . Hyaluronic acid as adjunctive to non-surgical and surgical periodontal therapy: a systematic review and meta-analysis. Clin Oral Investig. 2019; 23(9):3423-3435. DOI: 10.1007/s00784-019-03012-w. View